Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) Revenue (2016 - 2025)

cbdMD (YCBD) has disclosed Revenue for 10 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Revenue fell 1.89% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.1 million through Dec 2025, down 5.01% year-over-year, with the annual reading at $19.2 million for FY2025, 3.67% down from the prior year.
  • Revenue hit $5.0 million in Q4 2025 for cbdMD, up from $4.7 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $11.8 million in Q1 2021 to a low of $4.6 million in Q2 2025.
  • Historically, Revenue has averaged $6.9 million across 5 years, with a median of $6.0 million in 2023.
  • Biggest five-year swings in Revenue: rose 25.53% in 2021 and later plummeted 35.19% in 2023.
  • Year by year, Revenue stood at $9.3 million in 2021, then plummeted by 33.05% to $6.2 million in 2022, then fell by 13.86% to $5.4 million in 2023, then decreased by 4.87% to $5.1 million in 2024, then dropped by 1.89% to $5.0 million in 2025.
  • Business Quant data shows Revenue for YCBD at $5.0 million in Q4 2025, $4.7 million in Q3 2025, and $4.6 million in Q2 2025.